Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Envigo Opens Doors for Business | Contract Pharma
Breaking News

Envigo Opens Doors for Business

Created through the integration of Huntingdon Life Sciences, Harlan Laboratories, GFA, NDA Analytics and LSR associates

Huntingdon Life Sciences, Harlan Laboratories and three subsidiaries have announced that the combined companies have rebranded as Envigo.

“Today we are delighted to officially rebrand as Envigo,” said Brian Cass, chief executive officer, Envigo. “This marks a significant milestone for the five companies that came together to create Envigo and demonstrates the great progress we have made in our integration. Our customers are increasingly seeking partners who can deliver a variety of services in a coordinated manner, and the breadth of Envigo’s offering strengthens our ability to deliver on that need.”

Envigo employs 3,800 people and has sales approaching $500 million. The company is a top-three provider of non-clinical research services and research models and services to the pharmaceutical, chemical and crop protection industries, as well as academic institutions and government agencies worldwide.

“We have received very positive comments from customers to the on-going integration of our businesses and to our new name,” said Adrian Hardy, chief operating officer, Envigo. “Today we have become Envigo, and our goal is to establish the company as the number one partner for both customer service and scientific excellence.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters